172 related articles for article (PubMed ID: 21349418)
21. Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database.
Ter-Minassian M; Chan JA; Hooshmand SM; Brais LK; Daskalova A; Heafield R; Buchanan L; Qian ZR; Fuchs CS; Lin X; Christiani DC; Kulke MH
Endocr Relat Cancer; 2013 Apr; 20(2):187-96. PubMed ID: 23319495
[TBL] [Abstract][Full Text] [Related]
22. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.
Ito T; Igarashi H; Jensen RT
J Gastroenterol; 2012 Sep; 47(9):941-60. PubMed ID: 22886480
[TBL] [Abstract][Full Text] [Related]
23. Pregnant with metastatic neuroendocrine tumour of the ovary: what now?
Pistilli B; Grana C; Fazio N; Cavaliere A; Ferrari M; Bodei L; Baio S; Scambia G; Paganelli G; Peccatori F
Ecancermedicalscience; 2012; 6():240. PubMed ID: 22331988
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
Essler M; Gärtner FC; Neff F; Blechert B; Senekowitsch-Schmidtke R; Bruchertseifer F; Morgenstern A; Seidl C
Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):602-12. PubMed ID: 22237842
[TBL] [Abstract][Full Text] [Related]
25. Clinical review: Pituitary carcinoma: difficult diagnosis and treatment.
Heaney AP
J Clin Endocrinol Metab; 2011 Dec; 96(12):3649-60. PubMed ID: 21956419
[TBL] [Abstract][Full Text] [Related]
26. Cancer: a roadmap for the land of small tumors.
Jensen RT
Nat Rev Endocrinol; 2011 Jun; 7(6):319-21. PubMed ID: 21556022
[No Abstract] [Full Text] [Related]
27. Targeted radiotherapy with radiolabeled somatostatin analogs.
Nicolas G; Giovacchini G; Müller-Brand J; Forrer F
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):187-204, ix-x. PubMed ID: 21349419
[TBL] [Abstract][Full Text] [Related]
28. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Teunissen JJ; Kwekkeboom DJ; Valkema R; Krenning EP
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S27-51. PubMed ID: 22005114
[TBL] [Abstract][Full Text] [Related]
29. Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
Kwekkeboom DJ; Teunissen JJ; Kam BL; Valkema R; de Herder WW; Krenning EP
Hematol Oncol Clin North Am; 2007 Jun; 21(3):561-73; x. PubMed ID: 17548040
[TBL] [Abstract][Full Text] [Related]
30. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Kwekkeboom DJ; Mueller-Brand J; Paganelli G; Anthony LB; Pauwels S; Kvols LK; O'dorisio TM; Valkema R; Bodei L; Chinol M; Maecke HR; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():62S-6S. PubMed ID: 15653653
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.
Kwekkeboom DJ; de Herder WW; Krenning EP
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):173-85, ix. PubMed ID: 21349418
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP
Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
